The impact of respiratory syncytial virus on the NHS, society and economy in the UK
Researchers estimate the total economic impact of respiratory syncytial virus (RSV) to be around £80 million each year, based on a rapid evidence assessment to model the disease's wider societal and economic burden in the UK.